Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library.

ChemMedChem 2015 Nov 18;10(11):1809-20. Epub 2015 Sep 18.

Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, UK.

A screen of a focused kinase inhibitor library against Trypanosoma brucei rhodesiense led to the identification of seven series, totaling 121 compounds, which showed >50 % inhibition at 5 μm. Screening of these hits in a T. b. brucei proliferation assay highlighted three compounds with a 1H-imidazo[4,5-b]pyrazin-2(3H)-one scaffold that showed sub-micromolar activity and excellent selectivity against the MRC5 cell line. Subsequent rounds of optimisation led to the identification of compounds that exhibited good in vitro drug metabolism and pharmacokinetics (DMPK) properties, although in general this series suffered from poor solubility. A scaffold-hopping exercise led to the identification of a 1H-pyrazolo[3,4-b]pyridine scaffold, which retained potency. A number of examples were assessed in a T. b. brucei growth assay, which could differentiate static and cidal action. Compounds from the 1H-imidazo[4,5-b]pyrazin-2(3H)-one series were found to be either static or growth-slowing and not cidal. Compounds with the 1H-pyrazolo[3,4-b]pyridine scaffold were found to be cidal and showed an unusual biphasic nature in this assay, suggesting they act by at least two mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmdc.201500300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648050PMC
November 2015
66 Reads

Publication Analysis

Top Keywords

led identification
12
trypanosoma brucei
8
1h-pyrazolo[34-b]pyridine scaffold
8
compounds 1h-imidazo[45-b]pyrazin-23h-one
8
compounds
5
properties general
4
dmpk properties
4
metabolism pharmacokinetics
4
pharmacokinetics dmpk
4
suffered poor
4
solubility scaffold-hopping
4
scaffold-hopping exercise
4
poor solubility
4
drug metabolism
4
series suffered
4
general series
4
good vitro
4
excellent selectivity
4
selectivity mrc5
4
activity excellent
4

References

(Supplied by CrossRef)

Barrett et al.
Br. J. Pharmacol. 2007

Brun et al.
Future Microbiol. 2011

Cohen et al.
Nat. Rev. Drug Discovery 2002

Parsons et al.
BMC Genomics 2005

Naula et al.
Biochim. Biophys. Acta Proteins Proteomics 2005

Doerig et al.
Biochim. Biophys. Acta Proteins Proteomics 2004

Frearson et al.
Trends Parasitol. 2007

Wyatt et al.
Curr. Top. Med. Chem. 2011

Hammarton et al.
Mol. Microbiol. 2007

Cleghorn et al.
ChemMedChem 2011

Gilbert et al.
J. Med. Chem. 2013

Similar Publications